Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that health care providers should offer culturally competent care and more research is needed to improve health outcomes for transgender individuals.

New male hormonal contraceptives show promise but need more research on long-term effects and funding for larger trials.

FPHL causes hair loss in women due to genetics and hormones; minoxidil and anti-androgens are treatments, and early intervention is advised.

Polycystic ovary syndrome (PCOS) was first described in 1721, officially diagnosed in the 1990s, and is now known to be partly genetic and linked to insulin resistance, with increased risk of cardiovascular disease and carbohydrate metabolism issues.

Greek women with PCOS have a higher risk of metabolic syndrome and are more likely to be overweight compared to healthy controls.

Cross-sex hormone therapy is important for managing gender dysphoria and requires careful monitoring and healthcare provider education.

More research is needed on the health effects of hormone therapy for transgender and nonbinary people.

People with Lichen Planopilaris are more likely to have autoimmune diseases, especially Systemic Lupus Erythematosus, and less likely to have diabetes and some other common conditions.

People with alopecia areata have higher levels of a heart disease marker than those without hair loss.

Genetic counselors should be culturally skilled and aware of transgender patients' unique health risks and needs.

Patients with oral lichen planus or oral lichenoid reactions had worse cholesterol levels and a higher risk of obesity compared to healthy individuals.

Premature hair graying may be a sign of increased risk for heart disease, indicating biological age is more important than actual age.

The document concludes that more research is needed to fully understand the causes of PCOS.

Metabolic syndrome is more common in people with early-onset androgenic alopecia.

Older obese women with PCOS have higher cardiovascular and metabolic risks despite lower androgen levels.

COVID-19 and hypopituitarism (reduced pituitary gland function) are linked, with the latter's related health issues potentially worsening COVID-19 outcomes, and COVID-19 possibly increasing risk for pituitary complications.

Young men with early hair loss have slightly worse blood sugar and fat levels, suggesting possible health risks and need for monitoring.

Polycystic ovary syndrome is a common hormonal disorder in women, linked to increased risk of metabolic and heart diseases, and needs more research for better understanding and treatment.

People with hair loss have worse cholesterol levels, possibly linking hair loss to heart problems.

Taiwanese women with PCOS experience different symptoms based on age, with younger women facing more hormone imbalances and older women dealing with more metabolic issues.

Women with AGA have higher lipid levels, increasing heart disease risk.

A man developed heart problems after using a baldness treatment for 4 months, suggesting that people with heart issues should avoid this treatment.

Minoxidil may cause heart issues in guinea pigs, suggesting potential harm for users with heart conditions.

Young adults with hair loss face higher risk of stiff arteries.

Men with hair loss have higher BMI, waist size, blood pressure, and are linked to smoking and inactivity.

Oral minoxidil improves hair growth in men with hair loss, but caution needed for those with heart issues.

Ingesting minoxidil can cause serious heart issues; keep away from children and improve packaging.

Minoxidil, applied on the skin or taken orally, can improve hair growth in kids, but more research is needed due to possible side effects.

Early diagnosis and treatment of PCOS in young people is important to prevent long-term health problems.

Progesterone may help trans women with breast development and health, but more research is needed.